Wolfgang P. Fendler | IKIM MMLhttps://mml.kite.ume.de/authors/wolfgang-p.-fendler/Wolfgang P. FendlerHugoBlox Kit (https://hugoblox.com)en-usFri, 01 May 2026 00:00:00 +0000Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registryhttps://mml.kite.ume.de/publications/guberina-salvage-2026/Fri, 01 May 2026 00:00:00 +0000https://mml.kite.ume.de/publications/guberina-salvage-2026/Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyhttps://mml.kite.ume.de/publications/karpinski-combining-2024/Sun, 01 Sep 2024 00:00:00 +0000https://mml.kite.ume.de/publications/karpinski-combining-2024/Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimenshttps://mml.kite.ume.de/publications/darr-intraoperative-2023/Tue, 01 Aug 2023 00:00:00 +0000https://mml.kite.ume.de/publications/darr-intraoperative-2023/Evaluation of thresholding methods for the quantifcation of 68Ga‑PSMA‑11 PET molecular tumor volume and their efect on survival prediction in patients with advanced prostate cancer undergoing 177Lu‑PSMA‑617 radioligand therapyhttps://mml.kite.ume.de/publications/kim-evaluation-2023/Sun, 01 Jan 2023 00:00:00 +0000https://mml.kite.ume.de/publications/kim-evaluation-2023/PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysishttps://mml.kite.ume.de/publications/seifert-psma-2020/Tue, 01 Sep 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-psma-2020/